Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
39.8K
-
Shares change
-
+39.8K
-
Total reported value, excl. options
-
$199K
-
Value change
-
+$199K
-
Number of buys
-
1
-
Price
-
$5.01
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q4 2023
1 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q4 2023.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.8K shares
of 51.9M outstanding shares and own 0.08% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.25M shares), Nantahala Capital Management, LLC (2.25M shares), MILLENNIUM MANAGEMENT LLC (1.42M shares), VANGUARD GROUP INC (1.1M shares), Western Standard LLC (808K shares), AIGH Capital Management LLC (788K shares), Point72 Asset Management, L.P. (761K shares), Ikarian Capital, LLC (600K shares), CITIGROUP INC (450K shares), and J. Goldman & Co LP (430K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.